554 related articles for article (PubMed ID: 6594977)
1. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
2. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
3. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
Umezawa K; Kunimoto S; Takeuchi T
Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
[TBL] [Abstract][Full Text] [Related]
4. Influence of the structure of new anthracycline antibiotics on their biological properties.
Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
[TBL] [Abstract][Full Text] [Related]
5. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
6. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
Kanter PM; Schwartz HS
Cancer Res; 1979 Sep; 39(9):3661-72. PubMed ID: 476691
[TBL] [Abstract][Full Text] [Related]
7. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
8. [Immunomodulation by antitumor antibiotics].
Ishizuka M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of several anthracyclines on mitochondrial respiration and coenzyme Q10 protection.
Solaini G; Ronca G; Bertelli A
Drugs Exp Clin Res; 1985; 11(8):533-7. PubMed ID: 3869924
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydropyranyl derivatives of daunomycin and adriamycin.
Umezawa H; Takahashi Y; Kinoshita M; Naganawa H; Masuda T; Ishizuka M; Tatsuta K; Takeuchi T
J Antibiot (Tokyo); 1979 Oct; 32(10):1082-4. PubMed ID: 528373
[No Abstract] [Full Text] [Related]
11. Antitumour activity of new semi-synthetic anthracyclines containing fluorotalopyranose.
Umezawa K; Takeuchi T; Komuro K; Nosaka C; Kunimoto S; Tsuchiya T; Takagi Y; Umezawa S; Umezawa H
Drugs Exp Clin Res; 1988; 14(7):429-34. PubMed ID: 3240703
[TBL] [Abstract][Full Text] [Related]
12. Experimental evaluation of anthracycline analogs.
Casazza AM
Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
[TBL] [Abstract][Full Text] [Related]
14. Studies on the effects of anthracyclines on mitochondrial respiration in vitro.
Solaini G; Ronca G; Bertelli A
Drugs Exp Clin Res; 1985; 11(2):115-21. PubMed ID: 3869803
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of new N-substituted daunorubicin derivatives.
Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
Horton D; Khare A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305
[TBL] [Abstract][Full Text] [Related]
18. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
19. Mutagenicity of aclacinomycin A and daunomycin derivatives.
Umezawa K; Sawamura M; Matsushima T; Sugimura T
Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of new morpholino anthracyclines.
Komeshima N; Tsuruo T; Umezawa H
J Antibiot (Tokyo); 1988 Apr; 41(4):548-53. PubMed ID: 3163685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
